Characteristics of the 238 study patients
Characteristic . | Data . |
---|---|
Men, no. | 142 |
Median age, y (range) | 56 (30-71) |
Median creatinine, mg/dL (range) | 1.1 (0.7-3.5)* |
Median β2-microglobulin, mg/dL (range) | 2.53 (0.9-11.2)† |
Median bone marrow labeling index, % (range) | 0.4 (0-8.0) |
Median bone marrow plasma cells, % (range) | 20 (0-95) |
Median serum M protein, g/dL (range) | 1.6 (0-10.4)‡ |
Median urine protein, g/d (range) | 0.09 (0.007-10.4) |
Median time from diagnosis to bone marrow transplantation, mo (range) | 15.3 (3.7-87.5) |
Status at transplantation, no. of patients | |
Plateau | 70 |
Primary induction failure | 33 |
Relapse off therapy | 86 |
Relapse on therapy (resistant relapse) | 49 |
Characteristic . | Data . |
---|---|
Men, no. | 142 |
Median age, y (range) | 56 (30-71) |
Median creatinine, mg/dL (range) | 1.1 (0.7-3.5)* |
Median β2-microglobulin, mg/dL (range) | 2.53 (0.9-11.2)† |
Median bone marrow labeling index, % (range) | 0.4 (0-8.0) |
Median bone marrow plasma cells, % (range) | 20 (0-95) |
Median serum M protein, g/dL (range) | 1.6 (0-10.4)‡ |
Median urine protein, g/d (range) | 0.09 (0.007-10.4) |
Median time from diagnosis to bone marrow transplantation, mo (range) | 15.3 (3.7-87.5) |
Status at transplantation, no. of patients | |
Plateau | 70 |
Primary induction failure | 33 |
Relapse off therapy | 86 |
Relapse on therapy (resistant relapse) | 49 |